05
Nov
Ocriplasmin may treat vitreomacular adhesion
- Hits: 516
- 0 Comments
- Bookmark
Source: modernmedicine.com
Ocriplasmin (microplasmin, ThromboGenics) injected into the vitreous may be another option for treating symptomatic vitreomacular adhesion and macular holes. One injection of the drug seems to weaken the strength of the vitreomacular adhesion associated with pathologic posterior vitreous detachment (PVD) by targeting the fibronectin, laminin, and collagen fibers that keep the vitreous attached to the macula.
http://bit.ly/rZ2LDR
Ocriplasmin (microplasmin, ThromboGenics) injected into the vitreous may be another option for treating symptomatic vitreomacular adhesion and macular holes. One injection of the drug seems to weaken the strength of the vitreomacular adhesion associated with pathologic posterior vitreous detachment (PVD) by targeting the fibronectin, laminin, and collagen fibers that keep the vitreous attached to the macula.
http://bit.ly/rZ2LDR
Tags: Untagged
Comments
Please login first in order for you to submit comments
